Lazard Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 1031 to 1040 of 5801 Results

July 04, 2022
Australia, Japan

Komatsu announces agreement to acquire Mine Site Technologies

Undisclosed

July 04, 2022
United Kingdom, Italy

City Football Group, the world’s leading private owner and operator of football clubs with ownership of eleven clubs globally, including Manchester City FC, has acquired 80% stake of Palermo Football Club

Undisclosed

July 01, 2022
United Kingdom, United States

GSK to acquire Sierra Oncology

$1.9 Billion

July 01, 2022
United States

Sale of AllCells to Discovery Life Scienes

Undisclosed

June 30, 2022
France, Ireland

eir and InfraVia announce a partnership aimed at accelerating fibre-to-the-home roll-out across Ireland

Undisclosed

June 30, 2022
France, Netherlands

Equistone realises Fund V investment in Sicame through inaugural continuation fund deal

Undisclosed

June 30, 2022
France

The French specialty pharmaceutical company Juvisé Pharmaceuticals has successfully completed a €400M refinancing following the acquisition of the worldwide rights of Pylera®, an antimicrobial tri-therapy indicated for gastro-intestinal Helicobacter pylori infections

$418 Million

June 30, 2022
France

Groupe Colisée and Primonial REIM strengthen their privileged relationship around a portfolio of 5 residences in France

Undisclosed

June 29, 2022
Italy

UniCredit and Prelios sign partnership for management of Unlikely-To Pay loans

Undisclosed

June 28, 2022
United States

Tivity Health announces definitive agreement to be acquired by Stone Point Capital for $32.50 per share in cash

$2 Billion